Orchid Pharma Ltd
NSE:ORCHPHARMA

Watchlist Manager
Orchid Pharma Ltd Logo
Orchid Pharma Ltd
NSE:ORCHPHARMA
Watchlist
Price: 825.2 INR -0.36% Market Closed
Market Cap: 41.9B INR

Wall Street
Price Targets

ORCHPHARMA Price Targets Summary
Orchid Pharma Ltd

Wall Street analysts forecast ORCHPHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORCHPHARMA is 1 532.72 INR with a low forecast of 1 105.95 INR and a high forecast of 1 935.15 INR.

Lowest
Price Target
1 105.95 INR
34% Upside
Average
Price Target
1 532.72 INR
86% Upside
Highest
Price Target
1 935.15 INR
135% Upside
Orchid Pharma Ltd Competitors:
Price Targets
JUBLPHARMA
Jubilant Pharmova Ltd
48% Upside
AVDL
Avadel Pharmaceuticals PLC
111% Upside
600329
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
48% Upside
ENZY
Enzymatica AB (publ)
18% Downside
3692
Hansoh Pharmaceutical Group Company Ltd
20% Upside
PHO
Photocure ASA
52% Upside

Revenue
Forecast

Revenue Estimate
Orchid Pharma Ltd

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's revenue is -1%. The projected CAGR for the next 3 years is 33%.

-1%
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Orchid Pharma Ltd

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's operating income is 15%. The projected CAGR for the next 3 years is 64%.

15%
Past Growth
64%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Orchid Pharma Ltd

The compound annual growth rate of Orchid Pharma Ltd's net income for the next 3 years is 50%.

N/A
Past Growth
50%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORCHPHARMA's stock price target?
Price Target
1 532.72 INR

According to Wall Street analysts, the average 1-year price target for ORCHPHARMA is 1 532.72 INR with a low forecast of 1 105.95 INR and a high forecast of 1 935.15 INR.

What is Orchid Pharma Ltd's Revenue forecast?
Projected CAGR
33%

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's revenue is -1%. The projected CAGR for the next 3 years is 33%.

What is Orchid Pharma Ltd's Operating Income forecast?
Projected CAGR
64%

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's operating income is 15%. The projected CAGR for the next 3 years is 64%.

What is Orchid Pharma Ltd's Net Income forecast?
Projected CAGR
50%

The compound annual growth rate of Orchid Pharma Ltd's net income for the next 3 years is 50%.

Back to Top